Effects of the antiplatelet agents, dipyridamole and dilazep dihydrochloride, on in vivo platelet function and proteinuria.
D000293:Adolescent; D000328:Adult; D001381:Azepines / Q000627:therapeutic use*; D001792:Blood Platelets / Q000502:physiology*; D004109:Dilazep / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000097:blood / Q000188:drug therapy*
D001381:Azepines; D004176:Dipyridamole; D004109:Dilazep